Oxytocin's Effects on Behavior and Neural Activity During Social Cognition Tasks
Phase of Trial: Phase 0
Latest Information Update: 14 Aug 2017
At a glance
- Drugs Oxytocin (Primary)
- Indications Autistic disorder; Schizophrenia
- Focus Pharmacodynamics
- 08 Aug 2017 Status changed from recruiting to completed.
- 02 Dec 2015 Planned End Date changed from 1 Jan 2016 to 1 Aug 2016 as reported by ClinicalTrials.gov.
- 02 Dec 2015 Planned primary completion date changed from 1 Jan 2016 to 1 Aug 2016 as reported by ClinicalTrials.gov.